Physician profile
Jay Pradhan
NPI 1790755049
$1,305.49
in general payments reported to CMS, 2019-2025
13 companies · $83.39 in 2025
The $83.39 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $222 · 2021: $195 · 2022: $63.00 · 2023: $290 · 2024: $344 · 2025: $83.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $717.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $379.73 | 2019-2024 | Dragonfly Opstar |
| Inari Medical, INC. | $232.09 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $207.79 | 2023-2025 | Impella |
| Amgen INC. | $163.80 | 2024 | Repatha |
| Impulse Dynamics (USA) INC. | $101.56 | 2023 | Optimizer |
| Cardiovascular Systems INC. | $74.15 | 2021 | |
| Philips North America LLC | $61.22 | 2023 | |
| Sanofi-Aventis U.S. LLC | $17.65 | 2022 | |
| 180 Medical, INC. | $17.09 | 2022 | |
| Irhythm Technologies, INC. | $15.92 | 2023 | Zio Xt Patch |
| Veryan Medical Incorporated | $14.37 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $13.89 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $6.23 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Pradhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.